化学
脂多糖
一氧化氮合酶
炎症性肠病
一氧化氮
前列腺素E2
下调和上调
结肠炎
药理学
体内
生物化学
羧酸
酶
免疫学
内科学
医学
基因
生物
生物技术
疾病
有机化学
作者
Jingxuan Chen,Ling Li,Jin Liu,Sijie Yuan,Wenzhen Liao,Andrzej T. Slominski,Wěi Li,Michal Aleksander Zmijewski,Jianjun Chen
标识
DOI:10.1016/j.ejmech.2021.113468
摘要
Abstract A series of steroidal compounds based on 3-hydroxyandrosta-5,7-diene-17-carboxylic acid core structure were designed, synthesized and bio-evaluated for their anti-inflammatory potency. Among them, compound 5c, 6f, and 6q effectively inhibited the production of nitric oxide (NO) in lipopolysaccharide (LPS) stimulated RAW 264.7 macrophages. They inhibited the expression of inducible NO synthase (iNOS) and prostaglandin synthase-2 (COX-2) at mRNA level. Compound 6q displayed inhibitory effects on both iNOS and COX-2 expression in a concentration-dependent manner. Furthermore, 6q was found to effectively decrease the mRNA and protein levels of interleukin 6 (IL-6). Mechanically, 6q could potently downregulate NF-κB signaling via suppression of the Akt/PI3K pathway. Moreover, 6q demonstrated high in vivo anti-inflammatory activities in a mouse colitis model induced by dextran sulfate sodium (DSS). Taken together, these data indicate that 6q represents a novel and promising anti-inflammatory bowel diseases (IBD) agent worthy of further investigation.
科研通智能强力驱动
Strongly Powered by AbleSci AI